PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于2025年度日常关联交易确认及2026年度日常关联交易额度预计的公告 | 2026-04-21 | Chinese | |
| 关于南京药石科技股份有限公司年度募集资金存放、管理与实际使用情况的鉴证报告 | 2026-04-21 | Chinese | |
| 董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-04-21 | Chinese | |
| 董事会关于独立董事独立性自查情况的专项意见 | 2026-04-21 | Chinese | |
| 关于使用部分暂时闲置募集资金及自有资金进行现金管理的公告 | 2026-04-21 | Chinese | |
| 董事会审计委员会对公司2025年度内部控制自我评价报告的审核意见 | 2026-04-21 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40025079 | 关于2025年度日常关联交易确认及2026年度日常关联交易额度预计的公告 | 2026-04-21 | Chinese | ||
| 40025077 | 关于南京药石科技股份有限公司年度募集资金存放、管理与实际使用情况的鉴证报告 | 2026-04-21 | Chinese | ||
| 40025075 | 董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-04-21 | Chinese | ||
| 40025074 | 董事会关于独立董事独立性自查情况的专项意见 | 2026-04-21 | Chinese | ||
| 40025072 | 关于使用部分暂时闲置募集资金及自有资金进行现金管理的公告 | 2026-04-21 | Chinese | ||
| 40025070 | 董事会审计委员会对公司2025年度内部控制自我评价报告的审核意见 | 2026-04-21 | Chinese | ||
| 40025068 | 董事、高级管理人员薪酬管理制度 | 2026-04-21 | Chinese | ||
| 40025065 | 公司章程（2026年4月） | 2026-04-21 | Chinese | ||
| 40025062 | 关于2026年度开展外汇衍生品交易业务的可行性分析报告 | 2026-04-21 | Chinese | ||
| 40025061 | 关于2026年度对合并报表范围内子公司提供担保额度预计的公告 | 2026-04-21 | Chinese | ||
| 40025058 | 关于召开2025年度股东会的通知 | 2026-04-21 | Chinese | ||
| 40025056 | 关于控股股东、实际控制人部分股份质押及解除质押的公告 | 2026-02-12 | Chinese | ||
| 40025055 | 关于募集资金项目变更签署募集资金监管协议的公告 | 2026-02-06 | Chinese | ||
| 40025053 | 关于变更签字注册会计师的公告 | 2026-02-02 | Chinese | ||
| 40025050 | 2026年第一次临时股东会决议公告 | 2026-02-02 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.